FTC's Non-Compete Law Could Propel Rise in Trade Secrets Lawsuits

Trade secrets litigations and disputes have been on the rise in recent years, especially in fields with increased competition and sensitive data like the biopharma industry.

Given the Federal Trade Commission’s recent proposal to ban all non-compete agreements nationwide, the trend is likely to continue. If passed, the rule would force biotech companies to find another way to protect themselves against the unlawful sharing of confidential information.